Dodge & Cox 13D and 13G filings for BioMarin Pharmaceutical Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 1:21 pm Sale | 2023-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN | Dodge & Cox | 13,994,063 7.400% | -389,600 (-2.71%) | Filing |
| 2023-02-14 1:25 pm Sale | 2022-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN | Dodge & Cox | 14,383,663 7.700% | -441,386 (-2.98%) | Filing |
| 2022-02-14 12:48 pm Purchase | 2021-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN | Dodge & Cox | 14,825,049 8.100% | 5,028,125 (+51.32%) | Filing |